Heparin neutralization by an extract of the human placenta: measurements and the concept of placental barrier to heparin.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Gynecologic and Obstetric Investigation

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000294883PMID 1505807
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue anticoagulants in the human placenta: preliminary study with a heparin-like anticoagulant and review of the literature.

  1991cited by this paper
• Heparin and low molecular weight heparin: is anti-factor Xa activity important?

  1989cited by this paper
• Low Molecular Weight Heparin (CY 216) Does Not Cross the Placenta During the Third Trimester of Pregnancy

  1987cited by this paper
• Tissue factor (coagulation factor III) is present in placental microvilli and cofractionates with microvilli membrane proteins.

  1985cited by this paper
• Heparin binding properties of human histidine-rich glycoprotein. Mechanism and role in the neutralization of heparin in plasma.

  1983cited by this paper
• Maternal and fetal sequelae of anticoagulation during pregnancy.

  1980cited by this paper
• Evaluation of an amidolytic heparin assay method: increased sensitivity by adding purified antithrombin III.

  1977cited by this paper

• Fetal Effects of Drugs Commonly Used in Critical Care

  2011cites this paper
• Drug Permeation Across the Fetal Maternal Barrier

  2009cites this paper